The AUA Annual Meeting 2026 has successfully concluded in Washington, D.C., bringing together leading urologists, surgeons, and medical device professionals from around the world. As one of the most influential events in the field of urology, the meeting provided an excellent platform for academic exchange, product demonstrations, and discussions on the latest advances in urology surgery.
Over the three-day event, the Miconvey endoscope team had the opportunity to meet with urology specialists, hospital representatives, and distributors from multiple countries and regions. Through in-depth conversations and live product demonstrations, we gained valuable insights into current clinical needs and future market trends in ureteroscopy and endoscopic surgery.
Positive Feedback for the 7.5Fr Single-Use Ureteroscope
At this year's exhibition, Miconvey highlighted 7.5Fr Single-Use Ureteroscope, which attracted significant attention from visitors and industry experts.
The product received highly positive feedback for several key features:
- Clear and stable image quality
- Excellent maneuverability and deflection performance
- Slim 7.5Fr insertion tube design
- Reliable irrigation and access performance
- Ergonomic handling for improved procedural control
- Eco-friendly handle materials for enhanced sustainability
One of the most appreciated design features was the unique 6 o’clock working channel configuration. Many physicians noted that this design better matches the operating habits developed through years of using reusable ureteroscopes, allowing for a smoother transition to single-use devices without compromising procedural familiarity.
Strengthening Innovation in Urology
The enthusiastic response from clinicians and distributors further confirms the growing demand for high-performance disposable ureteroscopes that combine clinical reliability with cost efficiency.
These valuable discussions and clinical insights continue to inspire our product development efforts. Miconvey remains committed to expanding its urology portfolio and delivering innovative solutions that support safer and more efficient minimally invasive procedures.
As part of our broader endoscopy strategy, we will continue to introduce new products in the field of urology to enrich our offering and strengthen our competitiveness in the global market.
